# FDA 483 - Nephron Pharmaceuticals Corp. - August 17, 2012

Source: https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals-corp/20ae3bb3-aeb8-4dc3-a617-03709efbc605

> FDA 483 for Nephron Pharmaceuticals Corp. on August 17, 2012. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nephron Pharmaceuticals Corp.
- Inspection Date: 2012-08-17
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II

## Related Documents

- [483 - 2014-02-21](https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals-corp/e406463a-7f55-4e3b-ba70-d214fe456a85)
- [483 - 2011-06-17](https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals-corp/dd40d453-666f-4e51-85c7-7000f3aa817b)
- [483 - 2015-08-14](https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals-corp/1f3c6d8f-027d-4fb8-a003-5135818d528c)
- [483 - 2010-05-18](https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals-corp/94431a50-bfc4-4de9-8ac7-fe5cce232257)

## Related Officers

- [Angela Glenn](https://www.globalkeysolutions.net/people/angela-glenn/5ba5e1e2-883b-42c4-aae0-3564820723e8)
- [Charles R. Cote](https://www.globalkeysolutions.net/people/charles-r-cote/f6975cde-470e-4e86-bf1a-0337dcf5a367)

Company: https://www.globalkeysolutions.net/companies/nephron-pharmaceuticals-corp/0f5ad323-e857-47f3-adcf-4e39f1f62408

Office: https://www.globalkeysolutions.net/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6